Section Arrow
Quote
INM.NASDAQ
- InMed Pharmaceuticals Inc
Quotes are at least 15-min delayed:2025/11/16 21:14 EST
Regular Hours
Last
 1.705
-0.105 (-5.80%)
Day High 
1.82 
Prev. Close
1.81 
1-M High
2.26 
Volume 
54.01K 
Bid
1.7
Ask
1.75
Day Low
1.695 
Open
1.82 
1-M Low
1.56 
Market Cap 
5.08M 
Currency USD 
P/E 0.02 
%Yield -- 
10-SMA 1.74 
20-SMA 1.89 
50-SMA 2.09 
52-W High 8.27 
52-W Low 1.56 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.36/-21.39
Enterprise Value
5.38M
Balance Sheet
Book Value Per Share
4.13
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.94M
Operating Revenue Per Share
1.47
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.08-0.05-4.42%-- 
HIMSHims & Hers Health36.98+0.93+2.58%68.21PE
CGCCanopy Growth Corp1.07-0.03-2.73%-- 
AKBAAkebia Therapeutics1.67-0.09-5.11%-- 
AVDLAvadel Pharmaceuticals plc23.56+4.32+22.45%-- 
Quotes are at least 15-min delayed：2025/11/16 21:14 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.